BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17825543)

  • 1. Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol.
    Razvi N; Greaves P; Styles J; Edwards R; White IN
    Exp Toxicol Pathol; 2007 Nov; 59(3-4):177-85. PubMed ID: 17825543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine carcinoma in mice treated neonatally with tamoxifen.
    Newbold RR; Jefferson WN; Padilla-Burgos E; Bullock BC
    Carcinogenesis; 1997 Dec; 18(12):2293-8. PubMed ID: 9450472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen associated uterine pathology in rodents: relevance to women.
    Carthew P; Edwards RE; Nolan BM; Martin EA; Smith LL
    Carcinogenesis; 1996 Aug; 17(8):1577-82. PubMed ID: 8761412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens.
    Newbold RR; Liehr JG
    Cancer Res; 2000 Jan; 60(2):235-7. PubMed ID: 10667565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
    Luo S; Martel C; Sourla A; Gauthier S; Mérand Y; Belanger A; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(3):381-91. PubMed ID: 9359486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine histopathological changes induced by acute administration of tamoxifen and its modulation by sex steroid hormones.
    Sá SI; Maia J; Bhowmick N; Silva SM; Silva A; Correia-da-Silva G; Teixeira N; Fonseca BM
    Toxicol Appl Pharmacol; 2019 Jan; 363():88-97. PubMed ID: 30503537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and antiestrogens.
    Branham WS; Zehr DR; Chen JJ; Sheehan DM
    Teratology; 1988 Sep; 38(3):271-9. PubMed ID: 3227494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia.
    Carthew P; Edwards RE; Nolan BM; Martin EA; Heydon RT; White IN; Tucker MJ
    Carcinogenesis; 2000 Apr; 21(4):793-7. PubMed ID: 10753217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive tract abnormalities in female mice treated neonatally with tamoxifen.
    Taguchi O; Nishizuka Y
    Am J Obstet Gynecol; 1985 Mar; 151(5):675-8. PubMed ID: 3976766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.
    Sourla A; Luo S; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Dec; 138(12):5605-17. PubMed ID: 9389549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17beta--estradiol.
    Highman B; Norvell MJ; Shellenberger TE
    J Environ Pathol Toxicol; 1978; 1(1):1-30. PubMed ID: 722180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract.
    Newbold RR; Jefferson WN; Padilla-Banks E
    Reprod Toxicol; 2007; 24(2):253-8. PubMed ID: 17804194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.
    Green AR; Styles JA; Parrott EL; Gray D; Edwards RE; Smith AG; Gant TW; Greaves P; Al-Azzawi F; White IN
    Exp Toxicol Pathol; 2005 Mar; 56(4-5):255-63. PubMed ID: 15816354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive abnormalities in female mice exposed neonatally to various doses of coumestrol.
    Burroughs CD; Mills KT; Bern HA
    J Toxicol Environ Health; 1990 Jun; 30(2):105-22. PubMed ID: 2355401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciduoma formation in rats treated neonatally with the anti-estrogens, tamoxifen and MER-25.
    Ohta Y; Iguchi T; Takasugi N
    Reprod Toxicol; 1989; 3(3):207-12. PubMed ID: 2520524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovaries and uterus of tamoxifen-treated rats.
    Cirpan T; Terek MC; Ulukus M; Ulukus EC; Akman L; Kanit L
    Int J Gynecol Cancer; 2008; 18(1):141-5. PubMed ID: 17466037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice.
    Suzuki A; Sugihara A; Uchida K; Sato T; Ohta Y; Katsu Y; Watanabe H; Iguchi T
    Reprod Toxicol; 2002; 16(2):107-16. PubMed ID: 11955941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
    Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
    Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of uterine endometrial carcinogenesis in Donryu rats by tamoxifen.
    Yoshida M; Kudoh K; Katsuda S; Takahashi M; Ando J; Maekawa A
    Cancer Lett; 1998 Dec; 134(1):43-51. PubMed ID: 10381129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacology of oestrogens and catechol oestrogens: actions on the immature rat uterus in vivo and in vitro.
    Franks S; MacLusky NJ; Naftolin F
    J Endocrinol; 1982 Jul; 94(1):91-8. PubMed ID: 6284852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.